litlas
ログインアカウント作成

John A. Glaspy

1986–2025 年に発表

134
論文数
34,578
被引用数
89
h 指数
132
i10 指数

被引用数

John A. Glaspy の年別被引用数1971 年: 被引用 1 件1986 年: 被引用 1 件1987 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 3 件1990 年: 被引用 2 件1991 年: 被引用 14 件1992 年: 被引用 19 件1993 年: 被引用 14 件1994 年: 被引用 16 件1995 年: 被引用 20 件1996 年: 被引用 40 件1997 年: 被引用 49 件1998 年: 被引用 78 件1999 年: 被引用 103 件2000 年: 被引用 160 件2001 年: 被引用 186 件2002 年: 被引用 158 件2003 年: 被引用 189 件2004 年: 被引用 187 件2005 年: 被引用 178 件2006 年: 被引用 154 件2007 年: 被引用 163 件2008 年: 被引用 173 件2009 年: 被引用 143 件2010 年: 被引用 192 件2011 年: 被引用 168 件2012 年: 被引用 243 件2013 年: 被引用 225 件2014 年: 被引用 261 件2015 年: 被引用 397 件2016 年: 被引用 472 件2017 年: 被引用 464 件2018 年: 被引用 529 件2019 年: 被引用 1,191 件2020 年: 被引用 1,321 件2021 年: 被引用 1,161 件2022 年: 被引用 922 件2023 年: 被引用 601 件2024 年: 被引用 830 件2025 年: 被引用 336 件2026 年: 被引用 10 件1972〜1985 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,890 件、この内訳の 29.7%中国: 引用元論文 1,696 件、この内訳の 10.3%ドイツ: 引用元論文 921 件、この内訳の 5.6%イギリス: 引用元論文 900 件、この内訳の 5.5%イタリア: 引用元論文 782 件、この内訳の 4.8%フランス: 引用元論文 702 件、この内訳の 4.3%カナダ: 引用元論文 532 件、この内訳の 3.2%オーストラリア: 引用元論文 513 件、この内訳の 3.1%日本: 引用元論文 494 件、この内訳の 3%オランダ: 引用元論文 477 件、この内訳の 2.9%スイス: 引用元論文 474 件、この内訳の 2.9%スペイン: 引用元論文 468 件、この内訳の 2.8%
0%29.7%その他 21.9%

機関

分野

  • Medicine63.1%
  • Biochemistry, Genetics and Molecular Biology20.9%
  • Immunology and Microbiology11.1%
  • Nursing1.5%
  • Engineering1%
  • Neuroscience0.5%
  • その他1.9%

トピック

  • Cancer Immunotherapy and Biomarkers11.5%
  • Immunotherapy and Immune Responses7.8%
  • CAR-T cell therapy research5.6%
  • Immune Cell Function and Interaction3.3%
  • HER2/EGFR in Cancer Research2.5%
  • Melanoma and MAPK Pathways2.2%
  • その他67.1%

共著者

全論文

検索で開く
  1. PD-1 blockade induces responses by inhibiting adaptive immune resistance

    著者: Paul C. Tumeh, Christina L. Harview, Jennifer H. Yearley, I. Peter Shintaku, Emma Taylor, Lídia Robert, Bartosz Chmielowski, Marko Spasić, Gina Henry, Voicu Ciobanu, Alisha N. West, Manuel Carmona, Christine Kivork, Elizabeth Seja, Grace Cherry, Antonio Gutiérrez, Tristan Grogan, Christine Mateus, Gorana Tomasic, John A. Glaspy, Ryan Emerson, Harlan Robins, Robert H. Pierce, David Elashoff, Caroline Robert, Antoni Ribas - Nature 2014 被引用: 6,699

  2. Adjuvant Trastuzumab in HER2-Positive Breast Cancer

    著者: Dennis J. Slamon, W. Eiermann, Nicholas J. Robert, Tadeusz Pieńkowski, Miguel Martín, Michael F. Press, John R. Mackey, John A. Glaspy, Arlene Chan, Marek Pawlicki, Tamás Pintér, Vicente Valero, Mei-Ching Liu, Guido Sauter, Gϋnter von Minckwitz, F. Visco, Valerie Bée, Marc Buyse, Belguendouz Bendahmane, Isabelle Tabah-Fisch, Mary-Ann Lindsay, A. Riva, John Crown - New England Journal of Medicine 2011 被引用: 2,775

  3. Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma

    著者: Jason Chesney, Igor Puzanov, Frances A. Collichio, Parminder Singh, Mohammed Milhem, John A. Glaspy, Omid Hamid, Merrick I. Ross, Philip Friedlander, Claus Garbe, Theodore F. Logan, Axel Hauschild, Célèste Lebbé, Lisa Chen, Jaeyeon Kim, Jennifer Gansert, Robert H.I. Andtbacka, Howard L. Kaufman - Journal of Clinical Oncology 2017 被引用: 617

  4. Talimogene laherparepvec in combination with ipilimumab versus ipilimumab alone for advanced melanoma: 5-year final analysis of a multicenter, randomized, open-label, phase II trial

    著者: Jason Chesney, Igor Puzanov, Frances A. Collichio, Parminder Singh, Mohammed Milhem, John A. Glaspy, Omid Hamid, Merrick I. Ross, Philip Friedlander, Claus Garbe, Theodore F. Logan, Axel Hauschild, Célèste Lebbé, Harshada Joshi, Wendy Snyder, Janice M. Mehnert - Journal for ImmunoTherapy of Cancer 2023 被引用: 89

  5. Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy

    著者: Hubing Shi, Willy Hugo, Xiangju Kong, Aayoung Hong, Richard C. Koya, Gatien Moriceau, Thinle Chodon, Rongqing Guo, Douglas B. Johnson, Kimberly B. Dahlman, Mark C. Kelley, Richard Kefford, Bartosz Chmielowski, John A. Glaspy, Jeffrey A. Sosman, Nicolas van Baren, Georgina V. Long, Antoni Ribas, Roger S. Lo - Cancer Discovery 2013 被引用: 986

  6. Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial

    著者: Robert E. Coleman, Dianne M. Finkelstein, Carlos H. Barrios, Miguel Martín, Hiroji Iwata, Roberto Hegg, John A. Glaspy, Álvaro Montaño Periáñez, Katia Tonkin, Ines Deleu, Joohyuk Sohn, John Crown, Suzette Delaloge, Tian Dai, Ying Zhou, Danielle Jandial, Arlene Chan - The Lancet Oncology 2019 被引用: 257

  7. Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast Cancer

    著者: Silvia C. Formenti, Percy Lee, Sylvia Adams, Judith D. Goldberg, Xiaochun Li, Mike W. Xie, Josephine A. Ratikan, Carol Felix, Lin Hwang, Kym F. Faull, James Sayre, Sara A. Hurvitz, John A. Glaspy, Begoña Comı́n-Anduix, Sandra Demaria, Dörthe Schaue, William H. McBride - Clinical Cancer Research 2018 被引用: 249

  8. RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer

    著者: Nicholas J. Robert, Véronique Dièras, John A. Glaspy, Adam Brufsky, Igor Bondarenko, Oleg Lipatov, Edith A. Perez, Denise A. Yardley, Stephen Chan, Xian Zhou, S. Phan, Joyce O’Shaughnessy - Journal of Clinical Oncology 2011 被引用: 1,061

  9. Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers

    著者: Johann S. de Bono, Ramesh K. Ramanathan, Lida A. Mina, Rashmi Chugh, John A. Glaspy, Saeed Rafii, Stan B. Kaye, Jasgit C. Sachdev, John V. Heymach, David C. Smith, Joshua W. Henshaw, Ashleigh Herriott, Miranda Patterson, Nicola J. Curtin, Lauren A. Byers, Zev A. Wainberg - Cancer Discovery 2017 被引用: 383

  10. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

    著者: Matti Aapro, Yves Béguin, Carsten Bokemeyer, Mario Dicato, Pere Gascón, John A. Glaspy, Axel Hofmann, Hartmut Link, T. Littlewood, Heinz Ludwig, Anders Österborg, P. Pronzato, Valeria Santini, D. Schrijvers, R. Stauder, Kim Jordan, Jørn Herrstedt - Annals of Oncology 2017 被引用: 277

  11. PD-1 Blockade Expands Intratumoral Memory T Cells

    著者: Antoni Ribas, Daniel Sanghoon Shin, Jesse M. Zaretsky, Juliet Frederiksen, Andrew Cornish, Earl Avramis, Elizabeth Seja, Christine Kivork, Janet Siebert, Paula Kaplan‐Lefko, Xiaoyan Wang, Bartosz Chmielowski, John A. Glaspy, Paul C. Tumeh, Thinle Chodon, Dana Pe’er, Begoña Comı́n-Anduix - Cancer Immunology Research 2016 被引用: 410

  12. Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma

    著者: Neil Senzer, Howard L. Kaufman, Thomas Amatruda, Mike Nemunaitis, Tony Reid, Gregory A. Daniels, René González, John A. Glaspy, Eric D. Whitman, Kevin J. Harrington, Howard Goldsweig, Tracey Marshall, Colin Love, Robert S. Coffin, John Nemunaitis - Journal of Clinical Oncology 2009 被引用: 615

  13. Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial

    著者: Hope S. Rugo, Lasika Seneviratne, J. Thaddeus Beck, John A. Glaspy, Julio A. Peguero, Timothy Pluard, Navneet K. Dhillon, Leon C. Hwang, Chaitali Nangia, Ingrid A. Mayer, Timothy F. Meiller, Mark S. Chambers, Robert Sweetman, John Sabo, Jennifer K. Litton - The Lancet Oncology 2017 被引用: 225

  14. Preclinical Efficacy of the Antibody–Drug Conjugate CLDN6–23-ADC for the Treatment of CLDN6-Positive Solid Tumors

    著者: Martina S.J. McDermott, Neil A. O’Brien, Benjamin Hoffstrom, KeWei Gong, Ming Lu, Jun Zhang, Tong Luo, Min Liang, Weiping Jia, Jenny J. Hong, Kevin Chau, Simon Davenport, Bin Xie, Michael F. Press, Richard Panayiotou, Abram Handly‐Santana, Joan S. Brugge, Leonard Presta, John A. Glaspy, Dennis J. Slamon - Clinical Cancer Research 2023 被引用: 53

  15. Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma

    著者: Thinle Chodon, Begoña Comı́n-Anduix, Bartosz Chmielowski, Richard C. Koya, Zhongqi Wu, Martin Auerbach, Charles Ng, Earl Avramis, Elizabeth Seja, Arturo Villanueva, Tara A. McCannel, Akira Ishiyama, Johannes Czernin, Caius G. Radu, Xiaoyan Wang, David W. Gjertson, Alistair J. Cochran, Kenneth Cornetta, Deborah Jean Lee Wong, Paula Kaplan‐Lefko, Omid Hamid, Wolfram E. Samlowski, Peter A. Cohen, Gregory A. Daniels, Bijay Mukherji, Lili Yang, Jerome A. Zack, Donald B. Kohn, James R. Heath, John A. Glaspy, Owen N. Witte, David Baltimore, James S. Economou, Antoni Ribas - Clinical Cancer Research 2014 被引用: 253

  16. Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)

    著者: Hussein A. Tawbi, Peter Forsyth, F. Stephen Hodi, Christopher D. Lao, Stergios J. Moschos, Omid Hamid, Michael B. Atkins, Karl D. Lewis, Reena Thomas, John A. Glaspy, Sekwon Jang, Alain P. Algazi, Nikhil I. Khushalani, Michael A. Postow, Anna C. Pavlick, Marc S. Ernstoff, David A. Reardon, Igor Puzanov, Ragini R. Kudchadkar, Ahmad A. Tarhini, Anne Sumbul, Jasmine I. Rizzo, Kim Margolin - Neuro-Oncology 2021 被引用: 125

  17. Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion

    著者: Dilprit Bagga, Ling Wang, Robin Farias‐Eisner, John A. Glaspy, Srinivasa T. Reddy - National Academy of Sciences, Proceedings of the National Academy of Sciences 2003 被引用: 630

  18. Gemcitabine/nab-paclitaxel with pamrevlumab: a novel drug combination and trial design for the treatment of locally advanced pancreatic cancer

    著者: Vincent J. Picozzi, Adnan Alseidi, Jordan Winter, Michael J. Pishvaian, Kabir Mody, John A. Glaspy, Timothy Larson, Marc Matrana, Mairead Carney, Seth Porter, Elias Kouchakji, Flavio G. Rocha, Ewa Carrier - ESMO Open 2020 被引用: 74

  19. Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?

    著者: Ralph V. Boccia, John A. Glaspy, Jeffrey Crawford, Matti Aapro - The Oncologist 2022 被引用: 135

  20. Thrombocytopenia caused by the development of antibodies to thrombopoietin

    著者: Junzhi Li, Chun Yang, Yuping Xia, Amy M. Bertino, John A. Glaspy, Michael T. Roberts, David J. Kuter - Blood 2001 被引用: 684

  21. Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer

    著者: David Miles, Henri Roché, Miguel Martín, Timothy Perren, David Cameron, John A. Glaspy, David Dodwell, Joanne L. Parker, José Mayordomo, A. Trés, James L. Murray, Nuhad K. Ibrahim, the Theratope® Study Group - The Oncologist 2011 被引用: 253

  22. A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides

    著者: Lisa H. Butterfield, Antoni Ribas, Vivian B. Dissette, Yo Han Lee, Jin Q. Yang, Pilar de la Rocha, Sonia Duran, Jackie Hernandez, Elisabeth Seja, Douglas M. Potter, William H. McBride, Richard Finn, John A. Glaspy, James S. Economou - Clinical Cancer Research 2006 被引用: 230

  23. NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022

    著者: Elizabeth A. Griffiths, Vivek Roy, Laura Alwan, Kimo Bachiashvili, John H. Baird, Rita Cool, Shira Dinner, Mark B. Geyer, John A. Glaspy, Ivana Gojo, Ashley Hicks, Avyakta Kallam, Wajih Zaheer Kidwai, Dwight D. Kloth, Eric H. Kraut, Daniel J. Landsburg, Gary H. Lyman, Anjlee Mahajan, Ryan Miller, Victoria Nachar, Seema Patel, Shiven B. Patel, Lia Perez, Adam Poust, Fauzia Riaz, Rachel Rosovsky, Hope S. Rugo, Shayna Simon, Sumithira Vasu, Martha Wadleigh, Kelly Westbrook, Peter Westervelt, Ryan A. Berardi, Lenora A. Pluchino - Journal of the National Comprehensive Cancer Network 2022 被引用: 76

  24. A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer

    著者: Vina P. Nguyen, Katie M. Campbell, Theodore S. Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero, Maggie L. DiNome, Helena R. Chang, Denise K. Oseguera, Antoni Ribas, John A. Glaspy - Cancer Research Communications 2023 被引用: 19